This article is more than 5 years old. Information may no longer be current.

Anthem to cover artificial pancreas systems

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Anthem, the U.S.’s second largest health insurance company, will now cover artificial pancreas systems in response to JDRF’s Coverage2Control Campaign, according to a press release from JDRF.

This decision means that the 25 largest health insurers in the U.S. now cover artificial pancreas systems.

JDRF’s Coverage2Control Campaign, which launched in May 2017, urges insurance companies to cover these systems and to offer an affordable variety of options for the treatment of type 1 diabetes.

“This is a great victory for the [type 1 diabetes] community. By taking this tremendous step, Anthem is giving its members with diabetes access to this breakthrough in diabetes management,” Derek Rapp, president and CEO of JDRF, said in the release. “I am so proud of how thousands joined our Coverage2Control campaign to help make this happen. We applaud Anthem for this decision and will continue to push insurers to make changes to coverage that enable better diabetes management, such as keeping out-of-pocket insulin costs predictable and reasonable.”